Endogenous biomarkers play a pivotal role in comprehending drug-body interactions, shaping drug development, and propelling precision medicine forward. With our latest software release, the Simcyp™ Simulator introduces innovative features tailored to endogenous biomarkers.
In a comprehensive overview led by our expert presenter, Dr. Matthew Harwood, Principal Scientist in Translational DMPK, shares insights into:
- Endogenous biomarker outputs, overlays, and parameter estimation templates
- Available endogenous molecule files and their practical applications
Dr. Harwood covers a diverse range of topics, spanning from mechanistic models to the core principles of the simulator engine. Demonstrating workspace setup, outputs, and parameter estimation templates, he underscores:
- The flexibility in synthesizing endogenous molecules
- The crucial role of equilibration periods for precision in simulations
- The seamless integration of endogenous markers in PK and DDI studies
Explore further insights on endogenous biomarkers in our latest blog post: